0001127602-20-008102.txt : 20200227 0001127602-20-008102.hdr.sgml : 20200227 20200227144549 ACCESSION NUMBER: 0001127602-20-008102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200226 FILED AS OF DATE: 20200227 DATE AS OF CHANGE: 20200227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOSTER JAMES C CENTRAL INDEX KEY: 0001141722 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 20661122 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1228 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-02-26 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001141722 FOSTER JAMES C 251 BALLARDVALE STREET WILMINGTON MA 01887 1 1 Chairman, President and CEO Common Stock 2020-02-26 4 M 0 25124 73.70 A 311899 D Common Stock 2020-02-26 4 S 0 5311 160.398 D 306588 D Common Stock 2020-02-26 4 S 0 4098 161.3973 D 302490 D Common Stock 2020-02-26 4 S 0 6621 162.2099 D 295869 D Common Stock 2020-02-26 4 S 0 4198 163.307 D 291671 D Common Stock 2020-02-26 4 S 0 4896 164.1292 D 286775 D Common Stock 12800 I 2018 GRAT Common Stock 25000 I 2019 GRAT Common Stock 750 I By Trust Common Stock 2250 I By Trust Common Stock 340 I By Trust Common Stock 10000 I Held By Spouse Stock Options (Right to Buy) 73.70 2020-02-26 4 M 0 25124 0 D 2017-02-26 2021-02-26 Common Stock 25124 0 D This sale occurred pursuant to a 10b5-1 Trading Plan. This transaction was executed in multiple trades at prices ranging from $159.84 to $160.825. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $160.85 to $161.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $161.84 to $162.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $162.85 to $163.785. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $163.80 to $164.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ James C. Foster 2020-02-27